DMTK
Price
$0.61
Change
-$0.01 (-1.61%)
Updated
Apr 24, 6:59 PM EST
6 days until earnings call
PROF
Price
$7.80
Change
+$0.10 (+1.30%)
Updated
Apr 24, 6:59 PM EST
11 days until earnings call
Ad is loading...

Compare trend and price DMTK vs PROF

Header iconDMTK vs PROF Comparison
Open Charts DMTK vs PROFBanner chart's image
DermTech
Price$0.61
Change-$0.01 (-1.61%)
Volume$48.19K
CapitalizationN/A
Profound Medical
Price$7.80
Change+$0.10 (+1.30%)
Volume$5.56K
CapitalizationN/A
View a ticker or compare two or three
DMTK vs PROF Comparison Chart

Loading...

DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DMTK vs. PROF commentary
Apr 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMTK is a StrongSell and PROF is a Sell.

COMPARISON
Comparison
Apr 25, 2024
Stock price -- (DMTK: $0.62 vs. PROF: $7.70)
Brand notoriety: DMTK and PROF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DMTK: 49% vs. PROF: 24%
Market capitalization -- DMTK: $23.91M vs. PROF: $205.33M
DMTK [@Medical Specialties] is valued at $23.91M. PROF’s [@Medical Specialties] market capitalization is $205.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMTK’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • DMTK’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, DMTK is a better buy in the long-term than PROF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMTK’s TA Score shows that 5 TA indicator(s) are bullish while PROF’s TA Score has 2 bullish TA indicator(s).

  • DMTK’s TA Score: 5 bullish, 3 bearish.
  • PROF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, DMTK is a better buy in the short-term than PROF.

Price Growth

DMTK (@Medical Specialties) experienced а +0.28% price change this week, while PROF (@Medical Specialties) price change was -1.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.37%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +16.03%.

Reported Earning Dates

DMTK is expected to report earnings on Aug 06, 2024.

PROF is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Medical Specialties (+1.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for DMTK with price predictions.
OPEN
A.I.dvisor published
a Summary for PROF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PROF($205M) has a higher market cap than DMTK($23.9M). PROF YTD gains are higher at: -9.305 vs. DMTK (-64.800). PROF has higher annual earnings (EBITDA): -26.78M vs. DMTK (-97.89M). DMTK has more cash in the bank: 55.9M vs. PROF (26.2M). PROF has less debt than DMTK: PROF (7.94M) vs DMTK (54.4M). DMTK has higher revenues than PROF: DMTK (15.3M) vs PROF (7.2M).
DMTKPROFDMTK / PROF
Capitalization23.9M205M12%
EBITDA-97.89M-26.78M366%
Gain YTD-64.800-9.305696%
P/E RatioN/AN/A-
Revenue15.3M7.2M213%
Total Cash55.9M26.2M213%
Total Debt54.4M7.94M685%
FUNDAMENTALS RATINGS
DMTK vs PROF: Fundamental Ratings
DMTK
PROF
OUTLOOK RATING
1..100
5757
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
9477
P/E GROWTH RATING
1..100
40100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (51) in the null industry is somewhat better than the same rating for DMTK (96). This means that PROF’s stock grew somewhat faster than DMTK’s over the last 12 months.

PROF's Profit vs Risk Rating (89) in the null industry is in the same range as DMTK (100). This means that PROF’s stock grew similarly to DMTK’s over the last 12 months.

PROF's SMR Rating (97) in the null industry is in the same range as DMTK (98). This means that PROF’s stock grew similarly to DMTK’s over the last 12 months.

PROF's Price Growth Rating (77) in the null industry is in the same range as DMTK (94). This means that PROF’s stock grew similarly to DMTK’s over the last 12 months.

DMTK's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for PROF (100). This means that DMTK’s stock grew somewhat faster than PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMTKPROF
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 28 days ago
83%
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH36.661.39
+3.94%
Tri Pointe Homes
RJF127.141.66
+1.32%
Raymond James Financial
QNST17.250.19
+1.11%
QuinStreet
VHC5.560.06
+1.07%
VirnetX Holding Corp
ACIU2.38-0.04
-1.65%
AC Immune SA

DMTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMTK has been loosely correlated with SRTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DMTK jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMTK
1D Price
Change %
DMTK100%
+3.41%
SRTS - DMTK
34%
Loosely correlated
+0.29%
BIO - DMTK
32%
Poorly correlated
+1.84%
QTI - DMTK
30%
Poorly correlated
+1.72%
MYGN - DMTK
29%
Poorly correlated
+0.59%
TWST - DMTK
28%
Poorly correlated
+6.96%
More